Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page
- Check7 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a UI revision note (Revision: v3.6.0) were added, and the Intervention header formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.5%

- Check14 days agoChange DetectedThe footer now shows a new revision label: v3.5.5, replacing the previous v3.5.4. This represents a minor update to the page version.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe site revision tag was updated from v3.5.3 to v3.5.4. This appears to be a behind-the-scenes update with no visible changes to the study details or user-facing content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page header/footer is updated to show a newer ClinicalTrials.gov site revision (v3.5.3 instead of v3.5.2), reflecting a platform release rather than a change to the underlying clinical trial information.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check92 days agoChange Detected- Revision tag updated from v3.4.3 to v3.5.0; no substantive updates to the study details are evident.SummaryDifference0.1%

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.